236 related articles for article (PubMed ID: 25068480)
1. Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder.
Chen JJ; Liu Z; Fan SH; Yang DY; Zheng P; Shao WH; Qi ZG; Xu XJ; Li Q; Mu J; Yang YT; Xie P
Sci Rep; 2014 Jul; 4():5855. PubMed ID: 25068480
[TBL] [Abstract][Full Text] [Related]
2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
3. 2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder.
Xu XJ; Zheng P; Ren GP; Liu ML; Mu J; Guo J; Cao D; Liu Z; Meng HQ; Xie P
Mol Biosyst; 2014 Apr; 10(4):813-9. PubMed ID: 24457555
[TBL] [Abstract][Full Text] [Related]
4. Sex-specific urinary biomarkers for diagnosing bipolar disorder.
Chen JJ; Huang H; Zhao LB; Zhou DZ; Yang YT; Zheng P; Yang DY; He P; Zhou JJ; Fang L; Xie P
PLoS One; 2014; 9(12):e115221. PubMed ID: 25531985
[TBL] [Abstract][Full Text] [Related]
5. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
[TBL] [Abstract][Full Text] [Related]
7. Urinary Metabolomic Profiling to Identify Potential Biomarkers for the Diagnosis of Behcet's Disease by Gas Chromatography/Time-of-Flight-Mass Spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099052
[TBL] [Abstract][Full Text] [Related]
8. Urinary metabolite signature in bipolar disorder patients during depressive episode.
Chen JJ; Xie J; Zeng L; Zhou CJ; Zheng P; Xie P
Aging (Albany NY); 2019 Feb; 11(3):1008-1018. PubMed ID: 30721880
[TBL] [Abstract][Full Text] [Related]
9. New findings on urinary prostate cancer metabolome through combined GC-MS and
Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of urinary metabolite biomarkers for major depressive disorder.
Zheng P; Wang Y; Chen L; Yang D; Meng H; Zhou D; Zhong J; Lei Y; Melgiri ND; Xie P
Mol Cell Proteomics; 2013 Jan; 12(1):207-14. PubMed ID: 23111923
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Analysis of Membranous Glomerulonephritis: Identification of a Diagnostic Panel and Pathogenic Pathways.
Taherkhani A; Nafar M; Arefi-Oskouie A; Broumandnia N; Parvin M; Mahmoudieh L; Kalantari S
Arch Med Res; 2019 May; 50(4):159-169. PubMed ID: 31499475
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics for Age Discrimination of Ginseng Using a Multiplex Approach to HR-MAS NMR Spectroscopy, UPLC-QTOF/MS, and GC × GC-TOF/MS.
Yoon D; Choi BR; Ma S; Lee JW; Jo IH; Lee YS; Kim GS; Kim S; Lee DY
Molecules; 2019 Jun; 24(13):. PubMed ID: 31252608
[TBL] [Abstract][Full Text] [Related]
15. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics diagnostic approach to mustard airway diseases: a preliminary study.
Ghoochani BFNM; Aliannejad R; Oskouie AA; Rezaei-Tavirani M; Kalantari S; Naseri MT; Baghban AA; Parastar H; Aliakbarzadeh G
Iran J Basic Med Sci; 2018 Jan; 21(1):59-69. PubMed ID: 29372038
[TBL] [Abstract][Full Text] [Related]
17. Urinary metabolomics of pregnant women at term: a combined GC/MS and NMR approach.
Caboni P; Meloni A; Lussu M; Carta E; Barberini L; Noto A; Deiana SF; Mereu R; Ragusa A; Paoletti AM; Melis GB; Fanos V; Atzori L
J Matern Fetal Neonatal Med; 2014 Oct; 27 Suppl 2():4-12. PubMed ID: 25284171
[TBL] [Abstract][Full Text] [Related]
18. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
19. Metabolomic analysis to detect urinary molecular changes associated with bipolar depression.
Ren Y; Chen ZZ; Sun XL; Duan HJ; Tian JS; Wang JY; Yang H
Neurosci Lett; 2021 Jan; 742():135515. PubMed ID: 33227370
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
